In 2024, the biopharmaceutical industry in Pudong, Shanghai, achieved a remarkable milestone, reaching a scale of 420 billion yuan, reflecting a robust 10% year-on-year increase. This growth positions Pudong at the forefront among the three leading industries: integrated circuits, biopharmaceuticals, and artificial intelligence. Since 2019, Pudong has approved an impressive 21 domestically produced innovative drugs and 31 innovative medical devices, with this year adding 2 Class I innovative drugs and 4 more innovative medical devices to its portfolio.